However, a meta-analysis on SPECT and PET studies investigating DAT binding in ADHD compared to controls suggests that a history of medication may lead to adaptation, resulting in higher DAT binding (10). The gene discussed is SLC6A3; the disease is attention deficit-hyperactivity disorder.